{"id":88203,"date":"2023-04-12T05:05:49","date_gmt":"2023-04-12T05:05:49","guid":{"rendered":"http:\/\/kuwaitnewsgazette.com\/?guid=684e65c19643138bff8eed8a9a2b12b3"},"modified":"2023-04-12T05:05:49","modified_gmt":"2023-04-12T05:05:49","slug":"rosen-national-trial-counsel-encourages-phathom-pharmaceuticals-inc-investors-to-inquire-about-securities-class-action-investigation-phat","status":"publish","type":"post","link":"https:\/\/kuwaitnewsgazette.com\/rosen-national-trial-counsel-encourages-phathom-pharmaceuticals-inc-investors-to-inquire-about-securities-class-action-investigation-phat\/","title":{"rendered":"ROSEN, NATIONAL TRIAL COUNSEL, Encourages Phathom Pharmaceuticals, Inc. Investors to Inquire About Securities Class Action Investigation \u2013 PHAT"},"content":{"rendered":"
\n

NEW YORK, April 11, 2023 (GLOBE NEWSWIRE) — WHY: <\/strong>Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) resulting from allegations that Phathom may have issued materially misleading business information to the investing public.<\/p>\n

SO WHAT:<\/strong> If you purchased Phathom securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses.<\/p>\n

WHAT TO DO NEXT: <\/strong>To join the prospective class action, go to https:\/\/rosenlegal.com\/submit-form\/?case_id=7943<\/a> or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com<\/a> or cases@rosenlegal.com<\/a> for information on the class action.<\/p>\n

WHAT IS THIS ABOUT:<\/strong> On August 2, 2022, before market hours, Phathom issued a press release entitled \u201cPhathom Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Updates\u201d which announced that \u201cwe detected trace levels of a nitrosamine in vonoprazan drug product in our post-approval testing as we prepared for commercial launch.\u201d Further, the press release announced that \u201c[t]he Company is working with the FDA and plans to obtain approval of and implement an additional test method, specification, including a proposed acceptable intake limit, and additional controls to address this impurity prior to releasing our first vonoprazan-based products to the market.\u201d Finally, Phathom announced that \u201c[t]hese additional activities will result in a delay of the planned VOQUEZNA DUAL PAK and VOQUEZNA TRIPLE PAK product launches.\u201d<\/p>\n

On this news, Phathom\u2019s stock price fell $2.61 per share, or 28%, to close at $6.46 per share on August 2, 2022.<\/p>\n

WHY ROSEN LAW: <\/strong>We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs\u2019 Bar. Many of the firm\u2019s attorneys have been recognized by Lawdragon and Super Lawyers.<\/p>\n

Follow us for updates on LinkedIn: https:\/\/www.linkedin.com\/company\/the-rosen-law-firm<\/a>, on Twitter: https:\/\/twitter.com\/rosen_firm<\/a> or on Facebook: https:\/\/www.facebook.com\/rosenlawfirm\/<\/a>.<\/p>\n

Attorney Advertising. Prior results do not guarantee a similar outcome.<\/p>\n

Contact Information:<\/p>\n

Laurence Rosen, Esq.
\nPhillip Kim, Esq.
\nThe Rosen Law Firm, P.A.
\n275 Madison Avenue, 40th Floor
\nNew York, NY 10016
\nTel: (212) 686-1060
\nToll Free: (866) 767-3653
\nFax: (212) 202-3827
\nlrosen@rosenlegal.com<\/a>
\npkim@rosenlegal.com<\/a>
\ncases@rosenlegal.com<\/a>
\nwww.rosenlegal.com<\/a><\/p>\n

GlobeNewswire Distribution ID 8805871<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

NEW YORK, April 11, 2023 (GLOBE NEWSWIRE) \u2014 WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) resulting from allegations that Phathom may have issued materially misleading business information to the investing public. SO WHAT: If you purchased [\u2026]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[31],"tags":[],"yoast_head":"\nROSEN, NATIONAL TRIAL COUNSEL, Encourages Phathom Pharmaceuticals, Inc. Investors to Inquire About Securities Class Action Investigation \u2013 PHAT - Kuwait News Gazette<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/kuwaitnewsgazette.com\/rosen-national-trial-counsel-encourages-phathom-pharmaceuticals-inc-investors-to-inquire-about-securities-class-action-investigation-phat\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ROSEN, NATIONAL TRIAL COUNSEL, Encourages Phathom Pharmaceuticals, Inc. Investors to Inquire About Securities Class Action Investigation \u2013 PHAT - Kuwait News Gazette\" \/>\n<meta property=\"og:description\" content=\"NEW YORK, April 11, 2023 (GLOBE NEWSWIRE) \u2014 WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) resulting from allegations that Phathom may have issued materially misleading business information to the investing public. SO WHAT: If you purchased [\u2026]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/kuwaitnewsgazette.com\/rosen-national-trial-counsel-encourages-phathom-pharmaceuticals-inc-investors-to-inquire-about-securities-class-action-investigation-phat\/\" \/>\n<meta property=\"og:site_name\" content=\"Kuwait News Gazette\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-12T05:05:49+00:00\" \/>\n<meta name=\"author\" content=\"kgadmin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"kgadmin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/kuwaitnewsgazette.com\/rosen-national-trial-counsel-encourages-phathom-pharmaceuticals-inc-investors-to-inquire-about-securities-class-action-investigation-phat\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/kuwaitnewsgazette.com\/rosen-national-trial-counsel-encourages-phathom-pharmaceuticals-inc-investors-to-inquire-about-securities-class-action-investigation-phat\/\"},\"author\":{\"name\":\"kgadmin\",\"@id\":\"https:\/\/kuwaitnewsgazette.com\/#\/schema\/person\/1d9e86302bbb52a7b9b849900591cb23\"},\"headline\":\"ROSEN, NATIONAL TRIAL COUNSEL, Encourages Phathom Pharmaceuticals, Inc. Investors to Inquire About Securities Class Action Investigation \u2013 PHAT\",\"datePublished\":\"2023-04-12T05:05:49+00:00\",\"dateModified\":\"2023-04-12T05:05:49+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/kuwaitnewsgazette.com\/rosen-national-trial-counsel-encourages-phathom-pharmaceuticals-inc-investors-to-inquire-about-securities-class-action-investigation-phat\/\"},\"wordCount\":525,\"publisher\":{\"@id\":\"https:\/\/kuwaitnewsgazette.com\/#organization\"},\"articleSection\":[\"Press Releases\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/kuwaitnewsgazette.com\/rosen-national-trial-counsel-encourages-phathom-pharmaceuticals-inc-investors-to-inquire-about-securities-class-action-investigation-phat\/\",\"url\":\"https:\/\/kuwaitnewsgazette.com\/rosen-national-trial-counsel-encourages-phathom-pharmaceuticals-inc-investors-to-inquire-about-securities-class-action-investigation-phat\/\",\"name\":\"ROSEN, NATIONAL TRIAL COUNSEL, Encourages Phathom Pharmaceuticals, Inc. Investors to Inquire About Securities Class Action Investigation \u2013 PHAT - Kuwait News Gazette\",\"isPartOf\":{\"@id\":\"https:\/\/kuwaitnewsgazette.com\/#website\"},\"datePublished\":\"2023-04-12T05:05:49+00:00\",\"dateModified\":\"2023-04-12T05:05:49+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/kuwaitnewsgazette.com\/rosen-national-trial-counsel-encourages-phathom-pharmaceuticals-inc-investors-to-inquire-about-securities-class-action-investigation-phat\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/kuwaitnewsgazette.com\/rosen-national-trial-counsel-encourages-phathom-pharmaceuticals-inc-investors-to-inquire-about-securities-class-action-investigation-phat\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/kuwaitnewsgazette.com\/rosen-national-trial-counsel-encourages-phathom-pharmaceuticals-inc-investors-to-inquire-about-securities-class-action-investigation-phat\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/kuwaitnewsgazette.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ROSEN, NATIONAL TRIAL COUNSEL, Encourages Phathom Pharmaceuticals, Inc. Investors to Inquire About Securities Class Action Investigation \u2013 PHAT\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/kuwaitnewsgazette.com\/#website\",\"url\":\"https:\/\/kuwaitnewsgazette.com\/\",\"name\":\"Kuwait News Gazette\",\"description\":\"News From Kuwait\",\"publisher\":{\"@id\":\"https:\/\/kuwaitnewsgazette.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/kuwaitnewsgazette.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/kuwaitnewsgazette.com\/#organization\",\"name\":\"Kuwait News Gazette\",\"url\":\"https:\/\/kuwaitnewsgazette.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/kuwaitnewsgazette.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/kuwaitnewsgazette.com\/wp-content\/uploads\/2020\/04\/kuwaitng-logo.png\",\"contentUrl\":\"https:\/\/kuwaitnewsgazette.com\/wp-content\/uploads\/2020\/04\/kuwaitng-logo.png\",\"width\":200,\"height\":101,\"caption\":\"Kuwait News Gazette\"},\"image\":{\"@id\":\"https:\/\/kuwaitnewsgazette.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/kuwaitnewsgazette.com\/#\/schema\/person\/1d9e86302bbb52a7b9b849900591cb23\",\"name\":\"kgadmin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/kuwaitnewsgazette.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/ff4aa10d4f36ab9dc3cce9e101792273?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/ff4aa10d4f36ab9dc3cce9e101792273?s=96&d=mm&r=g\",\"caption\":\"kgadmin\"},\"url\":\"https:\/\/kuwaitnewsgazette.com\/author\/kgadmin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ROSEN, NATIONAL TRIAL COUNSEL, Encourages Phathom Pharmaceuticals, Inc. Investors to Inquire About Securities Class Action Investigation \u2013 PHAT - Kuwait News Gazette","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/kuwaitnewsgazette.com\/rosen-national-trial-counsel-encourages-phathom-pharmaceuticals-inc-investors-to-inquire-about-securities-class-action-investigation-phat\/","og_locale":"en_US","og_type":"article","og_title":"ROSEN, NATIONAL TRIAL COUNSEL, Encourages Phathom Pharmaceuticals, Inc. Investors to Inquire About Securities Class Action Investigation \u2013 PHAT - Kuwait News Gazette","og_description":"NEW YORK, April 11, 2023 (GLOBE NEWSWIRE) \u2014 WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) resulting from allegations that Phathom may have issued materially misleading business information to the investing public. SO WHAT: If you purchased [\u2026]","og_url":"https:\/\/kuwaitnewsgazette.com\/rosen-national-trial-counsel-encourages-phathom-pharmaceuticals-inc-investors-to-inquire-about-securities-class-action-investigation-phat\/","og_site_name":"Kuwait News Gazette","article_published_time":"2023-04-12T05:05:49+00:00","author":"kgadmin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"kgadmin","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/kuwaitnewsgazette.com\/rosen-national-trial-counsel-encourages-phathom-pharmaceuticals-inc-investors-to-inquire-about-securities-class-action-investigation-phat\/#article","isPartOf":{"@id":"https:\/\/kuwaitnewsgazette.com\/rosen-national-trial-counsel-encourages-phathom-pharmaceuticals-inc-investors-to-inquire-about-securities-class-action-investigation-phat\/"},"author":{"name":"kgadmin","@id":"https:\/\/kuwaitnewsgazette.com\/#\/schema\/person\/1d9e86302bbb52a7b9b849900591cb23"},"headline":"ROSEN, NATIONAL TRIAL COUNSEL, Encourages Phathom Pharmaceuticals, Inc. Investors to Inquire About Securities Class Action Investigation \u2013 PHAT","datePublished":"2023-04-12T05:05:49+00:00","dateModified":"2023-04-12T05:05:49+00:00","mainEntityOfPage":{"@id":"https:\/\/kuwaitnewsgazette.com\/rosen-national-trial-counsel-encourages-phathom-pharmaceuticals-inc-investors-to-inquire-about-securities-class-action-investigation-phat\/"},"wordCount":525,"publisher":{"@id":"https:\/\/kuwaitnewsgazette.com\/#organization"},"articleSection":["Press Releases"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/kuwaitnewsgazette.com\/rosen-national-trial-counsel-encourages-phathom-pharmaceuticals-inc-investors-to-inquire-about-securities-class-action-investigation-phat\/","url":"https:\/\/kuwaitnewsgazette.com\/rosen-national-trial-counsel-encourages-phathom-pharmaceuticals-inc-investors-to-inquire-about-securities-class-action-investigation-phat\/","name":"ROSEN, NATIONAL TRIAL COUNSEL, Encourages Phathom Pharmaceuticals, Inc. Investors to Inquire About Securities Class Action Investigation \u2013 PHAT - Kuwait News Gazette","isPartOf":{"@id":"https:\/\/kuwaitnewsgazette.com\/#website"},"datePublished":"2023-04-12T05:05:49+00:00","dateModified":"2023-04-12T05:05:49+00:00","breadcrumb":{"@id":"https:\/\/kuwaitnewsgazette.com\/rosen-national-trial-counsel-encourages-phathom-pharmaceuticals-inc-investors-to-inquire-about-securities-class-action-investigation-phat\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/kuwaitnewsgazette.com\/rosen-national-trial-counsel-encourages-phathom-pharmaceuticals-inc-investors-to-inquire-about-securities-class-action-investigation-phat\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/kuwaitnewsgazette.com\/rosen-national-trial-counsel-encourages-phathom-pharmaceuticals-inc-investors-to-inquire-about-securities-class-action-investigation-phat\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/kuwaitnewsgazette.com\/"},{"@type":"ListItem","position":2,"name":"ROSEN, NATIONAL TRIAL COUNSEL, Encourages Phathom Pharmaceuticals, Inc. Investors to Inquire About Securities Class Action Investigation \u2013 PHAT"}]},{"@type":"WebSite","@id":"https:\/\/kuwaitnewsgazette.com\/#website","url":"https:\/\/kuwaitnewsgazette.com\/","name":"Kuwait News Gazette","description":"News From Kuwait","publisher":{"@id":"https:\/\/kuwaitnewsgazette.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/kuwaitnewsgazette.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/kuwaitnewsgazette.com\/#organization","name":"Kuwait News Gazette","url":"https:\/\/kuwaitnewsgazette.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/kuwaitnewsgazette.com\/#\/schema\/logo\/image\/","url":"https:\/\/kuwaitnewsgazette.com\/wp-content\/uploads\/2020\/04\/kuwaitng-logo.png","contentUrl":"https:\/\/kuwaitnewsgazette.com\/wp-content\/uploads\/2020\/04\/kuwaitng-logo.png","width":200,"height":101,"caption":"Kuwait News Gazette"},"image":{"@id":"https:\/\/kuwaitnewsgazette.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/kuwaitnewsgazette.com\/#\/schema\/person\/1d9e86302bbb52a7b9b849900591cb23","name":"kgadmin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/kuwaitnewsgazette.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/ff4aa10d4f36ab9dc3cce9e101792273?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ff4aa10d4f36ab9dc3cce9e101792273?s=96&d=mm&r=g","caption":"kgadmin"},"url":"https:\/\/kuwaitnewsgazette.com\/author\/kgadmin\/"}]}},"_links":{"self":[{"href":"https:\/\/kuwaitnewsgazette.com\/wp-json\/wp\/v2\/posts\/88203"}],"collection":[{"href":"https:\/\/kuwaitnewsgazette.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/kuwaitnewsgazette.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/kuwaitnewsgazette.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/kuwaitnewsgazette.com\/wp-json\/wp\/v2\/comments?post=88203"}],"version-history":[{"count":0,"href":"https:\/\/kuwaitnewsgazette.com\/wp-json\/wp\/v2\/posts\/88203\/revisions"}],"wp:attachment":[{"href":"https:\/\/kuwaitnewsgazette.com\/wp-json\/wp\/v2\/media?parent=88203"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/kuwaitnewsgazette.com\/wp-json\/wp\/v2\/categories?post=88203"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/kuwaitnewsgazette.com\/wp-json\/wp\/v2\/tags?post=88203"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}